Citation Impact
Citing Papers
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 StandoutScience
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
2007
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial
2003
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease
2002
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
2005
Survivin, versatile modulation of cell division and apoptosis in cancer
2003
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
2008
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
2005
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Acute graft-vs-host disease
2001
Cancer drug resistance: an evolving paradigm
2013 Standout
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
2006
Viral Chemokine Receptors and Chemokines in Human Cytomegalovirus Trafficking and Interaction with the Immune System
2002
Comparison of ‘sequential’ versus ‘standard’ chemotherapy as re‐induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML‐R trial
2001
ACUTE BLEEDING AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION: ASSOCIATION WITH GRAFT VERSUS HOST DISEASE AND EFFECT ON SURVIVAL1
1999
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Graft-versus-host disease and the Th1/Th2 paradigm
1996
Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML
2008
Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance
2003 StandoutNobel
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Acute Myeloid Leukemia and the Position of Autologous Stem Cell Transplantation
2007
Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemia
2004
Targeting multidrug resistance in cancer
2006 Standout
Noncovalent drug-DNA binding interactions that inhibit and stimulate (A)BC excinuclease
1991 StandoutNobel
Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
1999 StandoutNobel
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Graft-versus-host disease
2009 Standout
Validating survivin as a cancer therapeutic target
2003
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
1997 StandoutNature
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Therapy-Related Myelodysplastic Syndrome
2007
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Pathophysiology of Graft-Versus-Host Disease
2006
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
1993
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome
2004
Bone Marrow Transplantation
1994
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
Foxp3 and Natural Regulatory T Cells
2003 StandoutNobel
Idarucizumab for Dabigatran Reversal
2015 Standout
Therapy-Related Myeloid Leukemia
2008
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation
2004
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
2001
Revealing the world of RNA interference
2004 StandoutNatureNobel
Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation
2001
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
A review of autologous hematopoietic cell transplantation
2000 Nobel
Diversity of nosocomialXanthomonas maltophilia (Stenotrophomonas maltophilia) as determined by ribotyping
1995
The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia
1995
Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
2005
Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation
2007
Development of Multidrug-Resistance Convertors: Sense or Nonsense?
2000
Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals
2007 Standout
Unrelated donor bone marrow transplantation using a chemotherapy‐only preparative regimen for adults with high‐risk acute myelogenous leukemia
2006
Strategies for reversing drug resistance
2003
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Specific Killing of Ph+Chronic Myeloid Leukemia Cells by a Lentiviral Vector-Delivered Anti-bcr/ablSmall Hairpin RNA
2003
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
2007
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
The Role of ABC Transporters in Clinical Practice
2003
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study
2001
Tumour stem cells and drug resistance
2005 Standout
Parallel Phase I Studies of Daunorubicin Given With Cytarabine and Etoposide With or Without the Multidrug Resistance Modulator PSC-833 in Previously Untreated Patients 60 Years of Age or Older With Acute Myeloid Leukemia: Results of Cancer and Leukemia Group B Study 9420
1999
Acute Myeloid Leukemia
2015 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720
2002
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
2002 Standout
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
1996
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nonintercalating DNA-binding ligands: Specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material
1986
VENO-OCCLUSIVE DISEASE OF THE LIVER
1955
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
1994
T-cell depletion of HLA-identical transplants in leukemia
1991
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
1997
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
1994
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation
2006
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor
1994
Cytokine dysregulation and acute graft-versus-host disease
1992
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Efflux of Rhodamine From CD56+ Cells as a Surrogate Marker for Reversal of P-Glycoprotein–Mediated Drug Efflux by PSC 833
1999
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies
2004
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells.
1998
Metal–Organic Frameworks in Biomedicine
2011 Standout
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
The Role of B7 Costimulation in CD4/CD8 T Cell Homeostasis
2000 StandoutNobel
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Tolerogenic Dendritic Cells
2003 StandoutNobel
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
1992
Late Effects of Hematopoietic Cell Transplantation Among 10-Year Adult Survivors Compared With Case-Matched Controls
2005
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Molecular Epidemiology of Stenotrophomonas maltophilia Isolated from Clinical Specimens from Patients with Cystic Fibrosis and Associated Environmental Samples
1998
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
1998
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia
2003
Works of J Cahn being referenced
Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) [see comments]
1990
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome
2005
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft
1999
Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B cell lymphoma: a preferential survivin–cyclin B link
2002
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy
2000
Typing of hospital strains of Xanthomonas maltophilia by pulsed-field gel electrophoresis
1994
A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society
2003
Marrow transplantation from HLA non-identical family donors for the treatment of leukaemia: a pilot study of 15 patients using additional immunosuppression and T-cell depletion
1988
Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)
1997
In situ hybridization for the detection of cytomegalovirus in blood or bone marrow leucocytes after allogeneic bone marrow transplantation
1994
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation
2003
Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group
1995
Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantation.
1991
Variability of the alloreactive T-cell response to human leukemic blasts.
1994
Intensive cytoreductive regimen and autologous bone marrow transplantation in leukemia. Present status and the future. A review
1983
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study
1996
Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) [see comments]
1990
Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement
1987
Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.
1995
Autoimmune-like thrombocytopenia after bone marrow transplantation [letter; comment]
1989
Detection of cytomegalovirus-infected cells in bone marrow biopsy specimens obtained before allogeneic bone marrow transplantation from donors and recipients.
1994
Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-Trans-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia Group
2004
Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group
1995
Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)
1995
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
1997